The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care

Table 1 Characteristics of cohort engaged in HCV care at UW Health during incarceration (2011–2015)

	Overall N (%)	HCV Treated N (%)	HCV Untreated N (%)	P-Value
Total	570 (100%)	328 (58%)	242 (42%)
Male	518 (91%)	294 (90%)	224 (93%)	0.2302
Hispanic/Latino^a	46 (9%)	22 (7%)	24 (10%)	0.2045
Race^b
White	378 (70%)	216 (70%)	162 (69%)	0.6467
Black	130 (24%)	75 (25%)	55 (24%)	0.7540
Other	28 (5%)	13 (4%)	15 (6%)	0.2693
1945–1965 birth cohort	308 (54%)	176 (54%)	132 (55%)	0.8337
Chronic conditions
Cirrhosis	110 (19%)	65 (20%)	45 (19%)	0.7148
HIV coinfection	27 (5%)	7 (2%)	20 (8%)	0.0007*
HBV coinfection	7 (1%)	1 (0.3%)	6 (2%)	0.0198*
Hypertension	175 (31%)	100 (30%)	75 (31%)	0.8974
Heart Disease	25 (4%)	17 (5%)	8 (3%)	0.2794
Diabetes	88 (15%)	50 (15%)	38 (16%)	0.8810
CKD	14 (2%)	8 (2%)	6 (2%)	0.9755
COPD	20 (4%)	8 (2%)	12 (5%)	0.1061
Cancer	26 (5%)	14 (4%)	12 (5%)	0.6962
Psychiatric disorders
Anxiety/Panic	138 (24%)	81 (25%)	57 (24%)	0.7532
Bipolar	26 (5%)	15 (5%)	11 (5%)	0.9875
Depression	220 (39%)	131 (40%)	89 (37%)	0.4434
Psychosis NOS	17 (3%)	8 (2%)	9 (4%)	0.3746
Substance use disorders
Alcohol dependence	294 (52%)	176 (54%)	118 (49%)	0.2474
Cocaine use	319 (56%)	188 (57%)	131 (54%)	0.4490
Injection drug use	355 (62%)	217 (66%)	138 (57%)	0.0262*
Advanced Fibrosis/Cirrhosis^c	97 (43%)	61 (63%)	36 (63%)	0.1138

*Statistically significant at α = 0.05
^aData on ethnicity was not recorded for 39 patients. Percentages are out of those whose ethnicity information was recorded (total N = 531)
^bDesignation of race was not recorded for 32 patients. Percentages are out of those whose race information was recorded (total N = 540)
^cOf the 570, diagnostic procedure results were recorded for 225 (39%). Diagnostic procedures included Liver biopsy, CT scan, MRI, and Fibroscan. Advanced fibrosis/cirrhosis percentages are out of those whose diagnostic results were recorded (total N = 225). Advanced fibrosis/ cirrhosis was identified by a Metavir score of 3 or 4 using a liver biopsy or Fibroscan, or interpretation of advanced cirrhosis or fibrosis on a CT scan or MRI by the physician

ISSN: 2194-7899